Kropivsek et al., Nature Cancer, 2023

Welcome to our Multiple Myeloma resource.

About us Dashboard Downloads

A multiple myeloma study.

Between 2017 and 2021, we, an interdisciplinary team of researchers and clinicians from the ETH Zurich and University Hospital Zurich have been carefully profiling left-over material from bone marrow aspirates of patients suffering from multiple myeloma (MM). The study was published at Nature Cancer.

Kropivsek et al., @ Nature Cancer Over 100 patient samples have been investigated using a variety of complementary technologies, providing unique insights into this cancer. These technologies include our image-based ex vivo drug screening platform, called pharmacoscopy. Pharmacoscopy enables us to measure the drug sensitivity of each individual cell in these samples, to a large panel of possible treatment options. Furthermore, using proteomics, we have measured the abundance of over 5000 proteins in the cancer cells present in each sample. We combine these data with eachother as well as anonymous clinical course of each patient to come to valuable insights.

The purpose of this website is to facilitate the sharing and re-use of our results.


Reduce. Reuse. Reanalyse.

Summary tables of our key results can be downloaded here. Please cite Kropivsek et al., Nature Cancer, 2023 if you use any of these data.


Questions and Answers.

Still not clear who we are and what we do? Or do you have other questions? Perhaps your questions are answered below, but don't hesitate to contact us if they're not.

What are you?

We are a publicly funded laboratory headed by Prof. Dr. Berend Snijder at the Institute of Molecular Systems Biology of the ETH Zurich in Switzerland. We are Systems Biologists, which in practice means that we combine large-scale cell biological experimentation with big data analysis and computational modeling. We do this to improve our ability to measure key aspects of cell biology, and to improve our understanding of life in health and disease.

Who funds you?

Our research is supported by public funding, which means we have a strong mandate to give back to society. Our funding includes an SNF Förderungsprofessur and an ERC Starting Grant:
Swiss National Science Foundation European Research Council ETH Zurich

Get in touch.

The MYELOMICS resource is under construction and maintained by the Snijder Lab. Feel free to reach out!